Creative Biolabs-Immuno-oncology

Anti-CD7 (clone 3A1G) SynExpress T7-BF-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR1736)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD7 (clone 3A1G). We employs the pAS (T7-BFP-IL-10-EcoRI) vector components and the SynExpress system of the Coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD7
Clone
3A1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
T7
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
pAS
Transformation Accuracy
0.96
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.